GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] the UK — has anyone got a straight answer on formulary — 28 comments in the full submission. View in context.
1.7k
c/insurancefights·submitted 3 months ago by u/coring_the_stopper

[Question] the UK — has anyone got a straight answer on formulary

Questionbranch of 11 comments

the UK — has anyone got a straight answer on formulary, and I want the answer with the reasoning attached rather than just the conclusion. Kept a log with every date, name of department and reference number. When they claimed no record of a call, I had the reference. Prior authorisation criteria are republished each…

Read the full submission and all 28 comments →

This branch

11 comments, started 3 months ago
u/marisol_moreau247 points·3 months ago·edited

Employer-sponsored plans may be regulated differently from individually purchased ones, which changes both the appeal route and which regulator hears a complaint.

replysharereportpermalink
u/saskia_lokken-32 points·3 months ago

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

replysharereportpermalink
u/edit_for_clarity1 point·3 months ago

That criterion is from the previous plan year. The current bulletin has different wording.

replysharereportpermalink
u/saskia_lokken1 point·3 months ago

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

replysharereportpermalink
u/nadia_trevino1 point·3 months ago·edited

New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.

saskia_lokken is right that this is documentation rather than persuasion. It took me a year to accept that.

replysharereportpermalink
u/line_petrov1 point·3 months ago

a template letter that quotes their own criteria back is the strongest one

replysharereportpermalink
u/sofia_nascimento1 point·3 months ago

Which country and which plan year are we talking about?

replysharereportpermalink
u/liv_vukovic1 point·3 months ago

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

replysharereportpermalink
[removed]1 point·3 months ago

[removed by moderator]

replysharereportpermalink
u/gustav_vermeulen1 point·3 months ago

Disagree with the tone strategy. Anger has never moved a determination; matching the criterion has.

replysharereportpermalink
u/saskia_lokken1 point·3 months ago·edited

Small fix — external review is independent of the plan. The second-level internal appeal is not.

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.